Background: The clinical presentations, MRI findings and outcomes for spinal cord infarction (SCI) are well documented in the West but scarce in the East. We investigated the clinical characteristics of SCI patients and further analyzed etiologies and prognostic factors in Chinese subjects. Methods: We reviewed all SCI patients from March 1993 to March 2007. Clinical symptoms, laboratory and imaging findings as well as outcomes were retrospectively analyzed. Results: Twenty-two patients (12 female) were identified; their mean age was 57.6 years. Nine patients (40.9%) had probable etiologies, while 13 were cryptogenic (59.1%). The primary etiologies were aortic diseases. Hypertension was the most common vascular risk factor (50%). Most patients (10/22 = 45.5%) had thoracolumbar lesions (mainly at T9–L1), while cervical lesions (9/22 = 40.9%) were the second most common (mainly at C4–C7). ‘Owl’s eyes’ signs were common with the anterior spinal artery (93.8%) and central cord infarctions (50%) but not in the posterior spinal artery or transverse spinal infarctions. After a mean follow-up of 18 months, only 10 patients (10/22 = 45%) had good outcomes (independent walking or walking with 1 aid). Conclusion: Most SCI patients had acute, monophasic symptoms, reaching nadir in <24 h. The subjects frequently had acute pain near their lesions before SCI signs/symptoms (16/22 = 72.7%). Initial severe weakness (Medical Research Council score ≤2) and a young age at onset (55 years old) are correlated with poor recovery of motor functions.

1.
Weidauer S, Nichtweiss M, Lanfermann H, Zanella FE: Spinal cord infarction: MR imaging and clinical features in 16 cases. Neuroradiology 2002;44:851–857.
2.
Salvador de la Barrera S, Barca-Buyo A, Montoto-Marques A, Ferreiro-Velasco ME, Cidoncha-Dans M, Rodriguez-Sotillo A: Spinal cord infarction: prognosis and recovery in a series of 36 patients. Spinal Cord 2001;39:520–525.
3.
Novy J, Carruzzo A, Maeder P, Bogousslavsky J: Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch Neurol 2006;63:1113–1120.
4.
Nedeltchev K, Loher TJ, Stepper F, Arnold M, Schroth G, Mattle HP, Sturzenegger M: Long-term outcome of acute spinal cord ischemia syndrome. Stroke 2004;35:560–565.
5.
Masson C, Pruvo JP, Meder JF, Cordonnier C, Touze E, De La Sayette V, Giroud M, Mas JL, Leys D; Study Group on Spinal Cord Infarction of the French Neurovascular Society: Spinal cord infarction: clinical and magnetic resonance imaging findings and short-term outcome. J Neurol Neurosurg Psychiatry 2004;75:1431–1435.
6.
Ross JS, Brant-Zawadzki M, Moore KR, Crim J, Chen MZ, Katzman GL: Diagnostic imaging spine; in Ross JS (ed): Spinal Cord Infarction. Salt Lake City, Amirsys, 2004, pp 26–29.
7.
Mawad ME, Rivera V, Crawford S, Ramirez A, Breitbach W: Spinal cord ischemia after resection of thoracoabdominal aortic aneurysms: MR findings in 24 patients. Am J Roentgenol 1990;155:1303–1307.
8.
Faig J, Busse O, Salbeck R: Vertebral body infarction as a confirmatory sign of spinal cord ischemic stroke: report of three cases and review of the literature. Stroke 1998;29:239–243.
9.
Yuh WT, Marsh EE 3rd, Wang AK, Russell JW, Chiang F, Koci TM, Ryals TJ: MR imaging of spinal cord and vertebral body infarction. AJNR Am J Neuroradiol 1992;13:145–154.
10.
Masson C, Boukriche Y, Berthelot JL, Colombani JM: Vertebra, rib and spinal cord infarction caused by probable fibrocartilaginous embolism. Cerebrovasc Dis 2001;12:142–143.
11.
Duprez TP, Danvoye L, Hernalsteen D, Cosnard G, Sindic CJ, Godfraind C: Fibrocartilaginous embolization to the spinal cord: serial MR imaging monitoring and pathologic study. AJNR Am J Neuroradiol 2005;26:496–501.
12.
Hughes JT, Brownell B: Cervical spondylosis complicated by anterior spinal artery thrombosis. Neurology 1964;14:1073–1077.
13.
Cheshire WP, Santos CC, Massey EW, Howard JF Jr: Spinal cord infarction: etiology and outcome. Neurology 1996;47:321–330.
14.
Iseli E, Cavigelli A, Dietz V, Curt A: Prognosis and recovery in ischaemic and traumatic spinal cord injury: clinical and electrophysiological evaluation. J Neurol Neurosurg Psychiatry 1999;67:567–571.
15.
Gallitto G, La Spina P, Granata F, Quartarone A, Savica R, Musolino R: Spinal grey matter infarction after aortic surgery: a case of persistent pure flaccid paraplegia. Cerebrovasc Dis 2005;19:345.
16.
Killen DA, Weinstein CL, Reed WA: Reversal of spinal cord ischemia resulting from aortic dissection. J Thorac Cardiovasc Surg 2000;119:1049–1052.
17.
Connolly JE: Prevention of spinal cord complications in aortic surgery. Am J Surg 1998;176:92–101.
18.
Fradet G, Jamieson WR, Janusz MT, Munro A, Ling H, Miyagishima RT, Tyers GF: Aortic dissection: a six year experience with 117 patients. Am J Surg 1988;155:697–700.
19.
Monteiro L, Leite I, Pinto JA, Stocker A: Spontaneous thoracolumbar spinal cord infarction: report of six cases. Acta Neurol Scand 1992;86:563–566.
20.
Baumgartner RW, Waespe W: Anterior spinal artery syndrome of the cervical hemicord. Eur Arch Psychiatry Clin Neurosci 1992;241:205–209.
21.
Cheshire WP Jr: Spinal cord infarction mimicking angina pectoris. Mayo Clin Proc 2000;75:1197–1199.
22.
Börnke C, Schmid G, Szymanski S, Schols L: Vertebral body infarction indicating midthoracic spinal stroke. Spinal Cord 2002;40:244–247.
23.
Suzuki T, Kawaguchi S, Takebayashi T, Yokogushi K, Takada J, Yamashita T: Vertebral body ischemia in the posterior spinal artery syndrome: case report and review of the literature. Spine 2003;28:E260–E264.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.